August 17, 2026

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 6.88% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a formidable player in the healthcare sector, specifically within the rapidly advancing medical devices industry. With a market capitalization of $19.2 billion,..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the Biotech Giant’s Potential in a Volatile Market

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has been at the forefront of mRNA technology since its inception in 2010. Headquartered in Cambridge, Massachusetts, Moderna is..

Summit Therapeutics Inc. (SMMT) Stock Analysis: A 114% Potential Upside Amid Biotech Innovations

Summit Therapeutics Inc. (SMMT), a pioneering player in the biotechnology sector, has captured significant attention among investors, not least because of its substantial potential upside of 114.32% as highlighted by..

ICON plc (ICLR) Stock Analysis: Strong Buy Ratings and 13.74% Potential Upside Highlight Investment Appeal

ICON plc (NASDAQ: ICLR), a leader in the healthcare sector through its specialization in diagnostics and research, is catching the eye of investors with a compelling growth narrative. Based in..

Genmab A/S (GMAB) Stock Analysis: A 21.59% Upside Potential Amid Robust Revenue Growth

As investors seek opportunities in the dynamic biotechnology sector, Genmab A/S (NASDAQ: GMAB) emerges as a compelling candidate with a market cap of $19.63 billion. Headquartered in Copenhagen, Denmark, Genmab..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 12.93% Potential Upside for Investors

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, particularly in the medical devices industry, presents a compelling case for investors seeking stable growth and income..

AbbVie Inc. (ABBV) Stock Analysis: Navigating Growth with a 10.74% Potential Upside

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor interest with its formidable presence in the pharmaceutical industry. Boasting a market capitalization of $440.83 billion,..

Gilead Sciences, Inc. (GILD) Stock Analysis: A Promising 13.77% Upside with Strong Buy Ratings

Gilead Sciences, Inc. (NASDAQ: GILD), a leader in the biopharmaceutical sector, continues to stand out as a compelling investment opportunity. As a major player in the healthcare industry, Gilead is..

Solventum Corporation (SOLV) Stock Analysis: Riding a 6% Upside with Strong Buy Ratings

Solventum Corporation (NASDAQ: SOLV) stands as a noteworthy player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $15.08 billion, Solventum has captured investor..

Encompass Health Corporation (EHC) Stock Analysis: A Potential 19.89% Upside on the Horizon

Encompass Health Corporation (NYSE: EHC) stands as a formidable entity in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $12.19 billion, the company..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating Opportunities with a 20% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, is making waves with its innovative approach to health information services. With a current market capitalization of..

Stryker Corporation (SYK) Stock Analysis: A Closer Look at Its 12.87% Upside Potential

Investors with an eye on the healthcare sector should take note of Stryker Corporation (NYSE: SYK), a leading player in the medical devices industry. With a robust market capitalization of..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Strong Buy with 16.27% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a formidable entity in the Healthcare sector, particularly in Diagnostics & Research, is catching investor attention with its promising growth outlook. With a market capitalization..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth with a Strong 162.15% Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, continues to capture investor attention with its robust financial metrics and..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with Robust Revenue Growth and Significant Potential Upside

Waters Corporation (NYSE: WAT), a formidable player in the healthcare sector, particularly within the diagnostics and research industry, presents a compelling case for investors. With a market capitalization of $40.47..

Molina Healthcare Inc (MOH) Stock Analysis: Healthcare Giant with a Balanced Analyst Outlook

Molina Healthcare Inc (NYSE: MOH) stands as a significant player in the healthcare sector, specifically within healthcare plans. With a market cap of $11.09 billion, this U.S.-based company is a..

Viatris Inc. (VTRS) Stock Analysis: Healthcare Giant with a 13.99% Upside and Strategic Collaborations

Viatris Inc. (NASDAQ: VTRS) is making waves in the healthcare sector as a prominent player in the drug manufacturing industry, specializing in both specialty and generic medications. With a market..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Challenges with a 9.67% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, commands attention from investors with its significant market presence and a potential upside of 9.67%. With a..

Fresenius Medical Care AG (FMS) Stock Analysis: Is There an 8.66% Upside for Investors?

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis and related services, stands as a pivotal player in the healthcare sector, specifically within the medical care facilities..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 24.62% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, is one of Japan’s most renowned drug manufacturers, focusing on both specialty and generic pharmaceuticals. With a..

Search

Funds

August 17, 2026

Search

Funds

August 17, 2026

FTSE 100

Funds